3D Systems Corp
NYSE:DDD

Watchlist Manager
3D Systems Corp Logo
3D Systems Corp
NYSE:DDD
Watchlist
Price: 2.21 USD -4.33% Market Closed
Market Cap: $284.5m

3D Systems Corp
Investor Relations

3D Systems Corp. is a holding company, which engages in the provision of comprehensive three-dimensional printing solutions. The company is headquartered in Rock Hill, South Carolina and currently employs 1,721 full-time employees. The company went IPO on 2011-03-26. The firm is principally engaged in providing three-dimensional (3D) printing and digital manufacturing solutions. Its products and solutions include 3D printers for plastics and metals, materials, software, maintenance and training services, and on demand solutions. Its solutions support applications in two key industry verticals: Healthcare, which includes dental and medical devices services; and Industrial, which includes aerospace and transportation. The firm offers a range of 3D printing technologies, including Stereolithography (SLA), Selective Laser Sintering (SLS), Direct Metal Printing (DMP), MultiJet Printing (MJP), ColorJet Printing and SLA based bioprinting. The company also offers 3D virtual reality simulators and simulator modules for medical applications. The company markets its products and services through subsidiaries in North America and South America, Europe and the Middle East, and the Asia Pacific region.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Nov 5, 2025
AI Summary
Q3 2025

Revenue Decline: 3D Systems reported Q3 revenue of $91.2 million, down 13.8% year-over-year and reflecting continued weakness in customer capital spending and macro uncertainty.

Cost Reduction Progress: The company continued to cut operating expenses, achieving a 24% YoY reduction (excluding divested Geomagic) and remains on track to deliver over $50 million in annualized savings by year-end.

Gross Margin Pressure: Gross margin dropped to 33% from 38% a year ago, mainly due to lower volumes, manufacturing variances, and the absence of a previous Regenerative Medicine milestone.

New Product Launches: 3D Systems launched new printer platforms, including the MJP 300W Plus for jewelry and the NextDent Jetted Denture Solution for dental labs, both receiving strong positive feedback.

Strategic Divestitures: The company completed the sale of its Oqton and 3DXpert software platforms, impacting Q4 revenue and margin by about $1.2 million and $1 million, respectively.

Healthcare Growth: MedTech and personalized health services showed solid growth, with MedTech up 8% YoY and expected to grow at double digits for the year.

Saudi Joint Venture Momentum: 3D Systems' joint venture in Saudi Arabia secured high-profile deals in energy and defense, including a $26 million framework agreement and a partnership with Lockheed Martin.

Guidance: Q4 guidance factors in the effects of software divestitures, and management expects operating expenses to continue declining through the first half of 2026.

Key Financials
Revenue
$91.2 million
Gross Margin
33%
Industrial Solutions Revenue
$48 million
Aerospace and Defense Revenue Growth
Nearly 50% YoY growth
Healthcare Solutions Revenue
$43 million
MedTech Revenue Growth
Up 8% YoY
PHS Year-to-Date Growth
10% through Q3
Operating Expenses
$44.7 million
Annualized Savings
Over $50 million by year-end
Adjusted EBITDA
-$10.8 million
Net Loss
-$18 million
Loss Per Share
-$0.14
Non-GAAP Loss Per Share
-$0.08
Total Cash
$114 million
Total Debt
$123 million
Q4 Revenue Impact from Software Divestiture
$1.2 million
Q4 Gross Margin Impact from Software Divestiture
$1 million
Earnings Call Recording
Other Earnings Calls

Management

Dr. Jeffrey Alan Graves Ph.D.
President, CEO & Director
No Bio Available
Mr. Reji Puthenveetil
Executive Vice President of Industrial Solutions, Additive Solutions & Chief Commercial Officer
No Bio Available
Mr. Jeffrey D. Creech
Executive VP, Principal Accounting Officer & CFO
No Bio Available
Ms. Phyllis B. Nordstrom
Executive VP, Chief People Officer & Chief Administrative Officer
No Bio Available
Dr. Charles W. Hull
Co-Founder, Executive VP, CTO of Regenerative Medicine & Director Emeritus
No Bio Available
Dr. Joseph Zuiker
Executive Vice President of Engineering & Operations
No Bio Available
Mr. Michael McCloskey
Treasurer & VP of Investor Relations
No Bio Available
Mr. Andrew W.B. Wright J.D.
Senior VP of General Counsel & Corporate Secretary
No Bio Available
Mr. Harriss T. Currie
President - Regenerative Medicine
No Bio Available

Contacts

Address
SOUTH CAROLINA
Rock Hill
333 Three D Systems Cir
Contacts
+18033263900.0
www.3dsystems.com